Eli Lilly and Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2020
Total Assets: $46.63B
Liabilities Breakdown FY2020
Total Liabilities: $40.99B
Asset Breakdown
Total Assets: $46.63B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.66B | 7.8% |
| Accounts Receivable | $5.88B | 12.6% |
| Inventory | $3.98B | 8.5% |
| Property, Plant & Equipment | $8.68B | 18.6% |
| Goodwill | $3.77B | 8.1% |
| Intangible Assets | $7.45B | 16.0% |
| Other Assets | $13.22B | 28.4% |
Liabilities Breakdown
Total Liabilities: $40.99B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.61B | 3.9% |
| Long-Term Debt | $16.59B | 40.5% |
| Other Liabilities | $22.80B | 55.6% |